Advertisement
Loading...

Hypera S.A.

HYPMYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$4.35
$-0.06(-1.36%)
U.S. Market is Open • 14:55
Advertisement

Hypera S.A. (HYPMY) Stock Overview

Explore Hypera S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.1B
P/E Ratio8.40
EPS (TTM)$0.52
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$5.02
3 Months$5.67
1 Year Target$4.57

HYPMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hypera S.A. (HYPMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.19, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.57.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 8.40 and a market capitalization of 3.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.23%
5-Day Change
-1.34%
1-Month Change
-3.07%
3-Month Change
-2.21%
6-Month Change
-10.16%
Year-to-Date (YTD) Change
6.76%
1-Year Change
3.51%
3-Year Change
-46.55%
5-Year Change
-36.03%
All-Time (Max) Change
-67.33%

Contact Information

55 11 3627 4206
Av. Magalhães de Castro, 4800, São Paulo, SP, 05676-120

Company Facts

10,481 Employees
IPO DateOct 15, 2010
CountryBR
Actively Trading

Frequently Asked Questions